Friday, October 7, 2022
wellness India Expo
Home Tags Johnson & Johnson

Tag: Johnson & Johnson

Digitally powered smart labs are the future of biopharma R&D: Experts

Leading biopharmaceutical scientists and industry leaders shared their valuable insights at the e-Conference on ‘Digital Laboratories: The Emerging Era of High-Tech R&D’ organized by BioVoice News on March 30, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

Corporate TB Pledge is a joint initiative between Central TB Division, Ministry of Health and Family Welfare and USAID. #BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers

World is on the cusp of making a technological shift: Alex...

mRNA vaccines have been possible because we digitized the genomic information from the virus itself, stated Alex Gorsky, Executive Chairman, Johnson & Johnson.................

Govt clarifies on MDR-TB drug ‘Bedaquiline’ controversy

The union health ministry has clarified that the Bedaquiline which is used in selective cases, is available only through Revised National TB Control Programme (RNTCP) and open market sale of the drug is not permitted in India as of now...…………..

Johnson & Johnson announces progress towards health for humanity goals

The company's annual 'Health for Humanity' report discloses progress on global commitments and highlights key achievements toward eradicating and preventing disease, reimagining care delivery and promoting lifelong health................

Small biotech companies dominate the pipeline for Microbiome-targeted therapies, says GlobalData

GlobalData anticipates ample opportunities for therapies targeting the skin microbiome as there are only three pipeline therapies in clinical development................

Healthcare firms finding obesity market a challenge to penetrate, says GlobalData

The latest failure of three anti-obesity drugs to provide the anticipated results could lead to the companies taking a cautious approach while investing to develop further drugs in the area.............

HITLAB & Unitus Seed Fund announce winners of 2018 HITLAB World...

The 4th HITLAB Innovators Summit held on February 10 at the Indian Institute of Technology, Delhi featured speakers from leading organizations including Johnson & Johnson, Stryker, IBM, PATH, Terumo, and more............................

Johnson & Johnson partners CSIR-IMTECH to develop new TB drugs

Memorandum of Understanding brings together best scientists from India and Johnson & Johnson to increase level and accelerate pace of innovation needed to make Tuberculosis history.......

Manufacturing India specific medical devices will increase cost to patient, deliberates...

Medical Technology Association of India during the course of deliberations at its recent board meeting appreciated the steps taken by the government so far but also called for amendments into various regulatory guidelines.....